Notes in Vulval cancer

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	FRS \| Vulva \| 1.1 \| Anatomy
Published	02/18/2024	FRS \| Vulva \| 1.2.1 \| Epidemiology
Published	02/18/2024	FRS \| Vulva \| 1.3 \| Clinical presentation
Published	02/18/2024	FRS \| Vulva \| 1.4 \| DIfferential diagnosis
Published	02/18/2024	FRS \| Vulva \| 1.5 \| Biologic behaviour
Published	02/18/2024	FRS \| Vulva \| 1.6 \| Workup
Published	02/18/2024	FRS \| Vulva \| 1.7.2 \| Staging \| Describe the FIGO 2017 staging system for vulva cancer
Published	02/18/2024	FRS \| Vulva \| 1.8 \| Prognostic factors
Published	02/18/2024	FRS \| Vulva \| 2.1 \| Pathologic classification
Published	02/18/2024	FRS \| Vulva \| 2.2.2 \| SCC \| Macroscopic appearance
Published	02/18/2024	FRS \| Vulva \| 2.2.1 \| SCC \| Epidemiology, RFs, biologic behaviour
Published	02/18/2024	FRS \| Vulva \| 2.2.3 \| SCC \| Microscopic appearance
Published	02/18/2024	FRS \| Vulva \| 2.3 \| Melanoma
Published	02/18/2024	FRS \| Vulva \| 2.4 \| Bartholin gland carcinoma
Published	02/18/2024	FRS \| Vulva \| 2.5 \| Basal cell caricnoma
Published	02/18/2024	FRS \| Vulva \| 2.6 \| Extramammary Paget's disease
Published	02/18/2024	FRS \| Vulva \| 2.7 \| Sarcoma
Published	02/18/2024	FRS \| Vulva \| 2.8.1 \| Field change / precursor lesions \| Squamous intraepithelial lesion (SIL) / Vulval intraepithelial neoplasm (VIN)
Published	02/18/2024	FRS \| Vulva \| 2.8.2 \| Field change / precursor lesions \| Lichen sclerosus
Published	02/18/2024	FRS \| Vulva \| 3.1 \| Management \| Overview
Published	02/18/2024	FRS \| Vulva \| 3.2.1 \| Surgery \| Management of primary
Published	02/18/2024	FRS \| Vulva \| 3.2.2 \| Surgery \| Evaluation of cN0 groin
Published	02/18/2024	FRS \| Vulva \| 3.2.3.1 \| Surgery \| Evidence \| LNDx vs. nodal RT \| GOG88 (Stehman, IJROBP 1992)
Published	02/18/2024	FRS \| Vulva \| 3.2.3.2 \| Surgery \| Kirby (Gyn Onc 2005) retrospective review
Published	02/18/2024	FRS \| Vulva \| 3.2.3.3 \| Surgery \| Evidence \| SLNBx \| Van Der Zee (JCO 2003) observational study
Published	02/18/2024	FRS \| Vulva \| 3.2.3.4 \| Surgery \| Evidence \| SLNBx \| GOG 173 (Levenbach JCO 2012)
Published	02/18/2024	FRS \| Vulva \| 3.2.3.5 \| Surgery \| Evidence \| SLNBx \| GROINSS-VI
Published	02/18/2024	FRS \| Vulva \| 3.2.3.6 \| Surgery \| Evidence \| GROINSS-V
Published	02/18/2024	FRS \| Vulva \| 3.2.3.7 \| Surgery \| Evidence \| SLNBx \| GROINSS-VII
Published	02/18/2024	FRS \| Vulva \| 3.2.3.7 \| Surgery \| Evidence \| SLNBx \| GROINSS-VIII (ongoing)
Published	02/18/2024	FRS \| Vulva \| 4.2 \| Definitive radiotherapy
Published	02/18/2024	FRS \| Vulva \| 4.1 \| Definitive chemoradiotherapy
Published	02/18/2024	FRS \| Vulva \| 4.3.1 \| Neoadjuvant chemoradiotherapy
Published	02/18/2024	FRS \| Vulva \| 4.3.2 \| Neoadjuvant chemoradiotherapy \| Evidence \| GOG 101 [T3/4 any N] (Moore IJROBP 1998)
Published	02/18/2024	FRS \| Vulva \| 4.3.4 \| Neoadjuvant chemoradiotherapy \| Evidence \| GOG 205 (Moore Gyn ONcol 2012)
Published	02/18/2024	FRS \| Vulva \| 4.3.3 \| Neoadjuvant chemoradiotherapy \| Evidence \| GOG 101 [N2/3] (Montana, IJROBP 2000)
Published	02/18/2024	FRS \| Vulva \| 4.3.5 \| Neoadjuvant chemoradiotherapy \| Evidence \| Beriwal retrospective IJROBP 2013
Published	02/18/2024	FRS \| Vulva \| 5 \| Chemotherapy
Published	02/18/2024	FRS \| Vulva \| 6 \| Palliation
Published	02/18/2024	FRS \| Vulva \| 7.1 \| Follow up
Published	02/18/2024	FRS \| Vulva \| 7.2 \| Prognosis
Published	02/18/2024	FRS \| Vulva \| 7.3 \| Management of recurrence
Published	02/18/2024	FRS \| Vulva \| 8.1 \| RT Technique \| Definitive / neoadjuvant
Published	02/18/2024	FRS \| Vulva \| 8.2 \| RT Technique \| Adjuvant
Published	02/18/2024	FRS \| Vulva \| 1.2.2 \| Aetiology
Published	02/18/2024	FRS \| Vulva \| 3.3 \| Surgery \| Management of cN1 nodes
Published	02/18/2024	FRS \| Vulva \| 1.7.1 \| Staging \| Describe the FIGO 2017 staging system for vulva cancer
Status	Last Update	Fields